发明名称 |
polipeptídeos de fator ix modificados e usos dos mesmos |
摘要 |
The invention relates to modified Factor IX polypeptides such as Factor IX polypeptides with one or more introduced glycosylation sites. The modified Factor IX polypeptides may exhibit increased in vitro or in vivo stability such as a longer plasma half-life. The invention also relates to methods of making modified Factor IX polypeptides, and methods of using modified Factor IX polypeptides, for example, to treat patients afflicted with hemophilia B. |
申请公布号 |
BRPI0910702(A2) |
申请公布日期 |
2016.07.05 |
申请号 |
BR2009PI10702 |
申请日期 |
2009.04.16 |
申请人 |
BAYER HEALTHCARE LLC;BAYER SCHERING PHARMA AKTIENGESELLSCHAFT |
发明人 |
ALAN BROOKS;CHANDRA PATEL;JOHN E. MURPHY;KORNELIA KIRCHNER;MARIAN SETO;ULRICH HAUPTS;UWE GRITZAN;XIAOQIAO JIANG |
分类号 |
C07K14/745 |
主分类号 |
C07K14/745 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|